Matches in Wikidata for { <http://www.wikidata.org/entity/Q92167821> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q92167821 description "article scientifique (publié 2019)" @default.
- Q92167821 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q92167821 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q92167821 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92167821 description "scientific article published on 01 January 2019" @default.
- Q92167821 description "wetenschappelijk artikel" @default.
- Q92167821 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q92167821 name "Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations" @default.
- Q92167821 name "Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations" @default.
- Q92167821 name "Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations" @default.
- Q92167821 type Item @default.
- Q92167821 label "Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations" @default.
- Q92167821 label "Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations" @default.
- Q92167821 label "Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations" @default.
- Q92167821 prefLabel "Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations" @default.
- Q92167821 prefLabel "Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations" @default.
- Q92167821 prefLabel "Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations" @default.
- Q92167821 P1433 Q92167821-609A6C12-9EE0-46B5-9582-C7A394943722 @default.
- Q92167821 P1476 Q92167821-0276656C-C067-4DF3-95FD-45D8EA41A2CA @default.
- Q92167821 P2093 Q92167821-33795AEC-69A5-4820-B2E3-30541CB3D733 @default.
- Q92167821 P2093 Q92167821-4B2C4926-384D-493A-B035-478D2A32A369 @default.
- Q92167821 P2093 Q92167821-CA8C6EB6-2716-437F-A5A0-B89900F6A932 @default.
- Q92167821 P2093 Q92167821-CCE9A360-99B7-4E20-BEB4-92E34609A847 @default.
- Q92167821 P2093 Q92167821-E9536174-9B28-41B0-9080-F7CB01DBCED5 @default.
- Q92167821 P2093 Q92167821-F3CD2D7E-6318-4992-AA3E-06E41C7925E6 @default.
- Q92167821 P304 Q92167821-AFCFC0F7-80E4-4471-98BC-A57525BF25F3 @default.
- Q92167821 P31 Q92167821-2FD2B3F8-8152-4B15-AC7E-5AA614332958 @default.
- Q92167821 P356 Q92167821-B60689AA-AF08-4DD3-B51E-BE4E114B7AE5 @default.
- Q92167821 P433 Q92167821-1EE3E62D-A904-440F-A7F6-E9D237EF602A @default.
- Q92167821 P478 Q92167821-B27CCE9B-8162-4926-BEB2-36A92EA1189D @default.
- Q92167821 P577 Q92167821-0E666253-0C72-470D-B7D0-ACC053BCBEA2 @default.
- Q92167821 P698 Q92167821-4A6B1FFF-95B6-4260-A886-BE54690E330B @default.
- Q92167821 P356 13506129.2019.1582520 @default.
- Q92167821 P698 31343329 @default.
- Q92167821 P1433 Q4749545 @default.
- Q92167821 P1476 "Quality of life assessment after 6 months of initiating treatment with tafamidis in patients with non-Val30Met mutations" @default.
- Q92167821 P2093 "Alejandra Gonzalez-Duarte" @default.
- Q92167821 P2093 "Benjamín Torres-Octavo" @default.
- Q92167821 P2093 "Carolina Domínguez-Rico" @default.
- Q92167821 P2093 "Claudia Mendoza-Tejeda" @default.
- Q92167821 P2093 "Karla Cárdenas-Soto" @default.
- Q92167821 P2093 "Omar Fueyo-Rodríguez" @default.
- Q92167821 P304 "57-58" @default.
- Q92167821 P31 Q13442814 @default.
- Q92167821 P356 "10.1080/13506129.2019.1582520" @default.
- Q92167821 P433 "sup1" @default.
- Q92167821 P478 "26" @default.
- Q92167821 P577 "2019-01-01T00:00:00Z" @default.
- Q92167821 P698 "31343329" @default.